|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-1-17
|
|
pubmed:abstractText |
It has been suggested that drug-metabolizing enzymes might play important roles in the development of anti-tuberculosis drug (ATD)-induced maculopapular eruption (MPE), as in ATD-induced hepatitis. We investigated the associations between the genetic polymorphisms of drug-metabolizing enzymes and ATD-induced MPE.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1432-1041
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
121-7
|
|
pubmed:meshHeading |
pubmed-meshheading:20941486-Adult,
pubmed-meshheading:20941486-Antitubercular Agents,
pubmed-meshheading:20941486-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:20941486-Arylamine N-Acetyltransferase,
pubmed-meshheading:20941486-Cytochrome P-450 CYP2E1,
pubmed-meshheading:20941486-Drug Eruptions,
pubmed-meshheading:20941486-Exanthema,
pubmed-meshheading:20941486-Female,
pubmed-meshheading:20941486-Genotype,
pubmed-meshheading:20941486-Haplotypes,
pubmed-meshheading:20941486-Humans,
pubmed-meshheading:20941486-Male,
pubmed-meshheading:20941486-Middle Aged,
pubmed-meshheading:20941486-Polymorphism, Single Nucleotide
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
NAT2, CYP2C9, CYP2C19, and CYP2E1 genetic polymorphisms in anti-TB drug-induced maculopapular eruption.
|
|
pubmed:affiliation |
Department of Internal Medicine, Hanyang University College of Medicine, Haengdang-dong 17, Seongdong-gu, Seoul, Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
